September 2010

Nanoparticles Could be Used to Improve Cancer Treatment, Diagnosis

Nanoparticles are finding early success in fighting the war on cancer. At Burnham Institute for Medical Research in La Jolla, CA, researchers have shown how anticancer nanoparticles can be used to improve MRI imaging of tumors and improve the dissemination of cancer drugs directly to the site of cancer. These beneficial results are due the […]

Nanoparticles Could be Used to Improve Cancer Treatment, Diagnosis Read More »

New Diagnostic Technique Could Result in Test for Mesothelioma

Reuters is reporting a new blood test that could identify mesothelioma at an early stage. The biotech company Somalogic, which specializes in developing diagnostic tests, announced a new technology that could allow doctors to identify mesothelioma in patients before they show visible symptoms. Somalogic scientists used blood samples from mesothelioma patients and were able to

New Diagnostic Technique Could Result in Test for Mesothelioma Read More »

Cancer Stem Cells More Complex Than Previously Thought

Studies into cancer stem cells and how they might be targeted for cancer treatment have been fervent over the past ten years. Indeed, there is a lot of evidence that suggests these unique cancer cells may lead to significant breakthroughs in treatment. However, as more and more research is being put into stem cells, researchers

Cancer Stem Cells More Complex Than Previously Thought Read More »

Palliative Care for Lung Cancer Improves Length, Quality of Life

New research suggests palliative care may not only ease suffering of lung cancer patients, but also increase lifespan. This insight comes on the heels of a study of 151 patients with advanced lung cancer. Among these patients, those that were given early palliative care typically been reserved for patients close to death were shown to

Palliative Care for Lung Cancer Improves Length, Quality of Life Read More »

Personalized Genetic Profile of Cancer Now Available to Public

A startup company known as Foundation Medicine has just been launched with the primary goal of offering personalized genetic profiles of cancer genomes. The initiative is the first such available service, and aims to help cancer patients receive targeted cancer treatment.   In recent years, doctors and researchers have come to realize the value of

Personalized Genetic Profile of Cancer Now Available to Public Read More »

Improving Adoption Rates of Orphan Drugs for Mesothelioma and Other Rare Diseases

Recently, research on a promising drug for a disease that currently affects 1,500 people in the United States annually was halted due the financial reasons, according to Peter Saltonstall of the National Organization for Rare Diseases. The root of these financial reasons stems from the cost of research versus the expected amount of profits that

Improving Adoption Rates of Orphan Drugs for Mesothelioma and Other Rare Diseases Read More »